Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 169, 113623
Abstract
No abstract availableKeywords
Funding Information
- The Belgian Science Policy Office
- Bijzonder Onderzoeksfonds (01J15517, 01N00814)
- Lambert Initiative for Cannabinoid Therapeutics and National Health and Medical Research Council (1161571)
This publication has 156 references indexed in Scilit:
- Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 LigandsMolecular Pharmacology, 2012
- Binding between a Distal C-Terminus Fragment of Cannabinoid Receptor 1 and Arrestin-2Biochemistry, 2011
- Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysisBMC Genomics, 2011
- Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor HeterodimersThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Peripheral, but Not Central, CB1 Antagonism Provides Food Intake–Independent Metabolic Benefits in Diet-Induced Obese RatsDiabetes, 2008
- In vitroandin vivocharacterization of A‐796260: a selective cannabinoid CB2receptor agonist exhibiting analgesic activity in rodent pain modelsBritish Journal of Pharmacology, 2008
- Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signalingNeuropharmacology, 2008
- Interaction of a fragment of the cannabinoid CB1 receptor C‐terminus with arrestin‐2FEBS Letters, 2007
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998